|
Volumn 25, Issue 12, 2006, Pages 1533-1537
|
Individualized chemotherapy based on drug sensitivity and resistance assay and MGMT protein expression for patients with malignant glioma--analysis of 42 cases
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
DACARBAZINE;
DRUG DERIVATIVE;
ETOPOSIDE;
METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;
TEMOZOLOMIDE;
ADOLESCENT;
ADULT;
ARTICLE;
ASTROCYTOMA;
BRAIN TUMOR;
CHEMICALLY INDUCED DISORDER;
CHILD;
DRUG RESISTANCE;
FEMALE;
GENE EXPRESSION REGULATION;
GLIOBLASTOMA;
GLIOMA;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
NAUSEA;
NEUTROPENIA;
REMISSION;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ASTROCYTOMA;
BRAIN NEOPLASMS;
CHILD;
CISPLATIN;
DACARBAZINE;
DRUG RESISTANCE, NEOPLASM;
ETOPOSIDE;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
GLIOBLASTOMA;
GLIOMA;
HUMANS;
MALE;
MIDDLE AGED;
NAUSEA;
NEUTROPENIA;
O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;
REMISSION INDUCTION;
YOUNG ADULT;
|
EID: 66549114249
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|